Shares of Korro Bio, Inc. (NASDAQ:KRRO – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $73.37, but opened at $75.22. Korro Bio shares last traded at $73.99, with a volume of 763 shares.
Analysts Set New Price Targets
Several analysts have commented on the stock. Royal Bank of Canada boosted their price target on shares of Korro Bio from $70.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 27th. HC Wainwright upped their target price on shares of Korro Bio from $100.00 to $115.00 and gave the company a “buy” rating in a research report on Thursday, March 28th. Piper Sandler restated an “overweight” rating and set a $180.00 target price on shares of Korro Bio in a research report on Wednesday, March 27th. Finally, BMO Capital Markets restated an “outperform” rating and set a $120.00 target price on shares of Korro Bio in a research report on Tuesday, March 26th.
Read Our Latest Research Report on Korro Bio
Korro Bio Stock Down 3.6 %
Institutional Trading of Korro Bio
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. North Star Investment Management Corp. purchased a new stake in Korro Bio in the 4th quarter worth about $48,000. Tower Research Capital LLC TRC bought a new position in Korro Bio in the 4th quarter worth about $190,000. Northern Trust Corp bought a new position in Korro Bio in the 4th quarter worth about $504,000. Verition Fund Management LLC bought a new position in Korro Bio in the 4th quarter worth about $2,784,000. Finally, Monashee Investment Management LLC bought a new position in Korro Bio in the 4th quarter worth about $4,352,000. 13.18% of the stock is owned by hedge funds and other institutional investors.
Korro Bio Company Profile
Korro Bio, Inc, a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc is based in Cambridge, Massachusetts.
Read More
- Five stocks we like better than Korro Bio
- How to Calculate Stock Profit
- Comprehensive PepsiCo Stock Analysis
- Consumer Discretionary Stocks Explained
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Korro Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Korro Bio and related companies with MarketBeat.com's FREE daily email newsletter.